Clinical Trial Update: Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED) [Phase 2]

View source ↗

Summary

This document provides an update on the Phase 2 efficacy and safety study of Mizoribine in active rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Mizoribine (mizoribine)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN